Impact of Baseline Clinical Variables on SGLT2i's Antiproteinuric Effect in Diabetic Kidney Disease.
Capelli I, Ribichini D, Provenzano M, Vetrano D, Aiello V, Cianciolo G, Vicennati V, Tomassetti A, Moschione G, Berti S, Pagotto U, La Manna G.
Capelli I, et al. Among authors: vicennati v.
Life (Basel). 2023 Apr 21;13(4):1061. doi: 10.3390/life13041061.
Life (Basel). 2023.
PMID: 37109590
Free PMC article.